Compare Ikapharmindo Putramas Tbk. (IKPM) vs Reksa Dana Indeks Batavia IDX30 ETF (XBID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ikapharmindo Putramas Tbk. vs Reksa Dana Indeks Batavia IDX30 ETF — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp199 (market cap 330.19B, 215.9K 24h volume), while Reksa Dana Indeks Batavia IDX30 ETF trades at Rp565 (market cap 15.84B, 111.8K 24h volume). The key difference: Ikapharmindo Putramas Tbk. is far larger — about 20.8× Reksa Dana Indeks Batavia IDX30 ETF's market cap, and Ikapharmindo Putramas Tbk. is more actively traded (215.9K versus 111.8K). Which is the better fit depends on your goals.
| IKPM | XBID | |
|---|---|---|
Market Cap | 330.19B | 15.84B |
Volume | 215.9K | 111.8K |
Lot | 2.16K | 1.12K |
Turnover | 42.44M | 50.11M |
Average Price | 196.56 | 448.24 |
Value | 42.44M | 50.11M |
Indicative Equilibrium Price | 199 | — |
Indicative Equilibrium Volume | 9 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →
